Investors in Iot

Kernel Capital is a Central Bank of Ireland regulated and UK Financial Conduct Authority authorised venture capital firm based in Ireland, focusing on investments in IP-rich companies across sectors like silicon chip design and data management. Since its establishment in 1999, Kernel Capital has raised €270M and led over 80 portfolio companies, completing significant transactions globally and raising €1.5BN+ for Irish technology companies. Their hands-on approach, combined with a deep global network, has delivered superior returns exceeding 20% Gross IRR, and in 2023, they launched Kernel Strategic, a boutique M&A business aimed at maximizing the value of deep IP companies.

Enterprise Equity is a venture capital firm with over 25 years of experience investing in internationally focused Irish companies. They provide funding for early-stage, high-growth technology businesses, offering more than just capital by delivering sound corporate governance and strategic advice. As the Investment General Partner of the AIB Seed Capital Fund with a committed fund size of €53 million, they support start-ups and early-stage companies in Ireland with significant growth potential.

Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.

Selenean Capital has successfully built a diverse portfolio of companies across aviation, defence, cybersecurity, transportation, medical technology, and renewables. The firm currently manages €175 million and is experiencing growth. Their strong performance is based on a comprehensive investment strategy tailored to the specific needs of both their portfolio companies and investors. They believe that future success requires continued innovation and diversification to ensure long-term sustainable growth. Their investments are underpinned by thorough technical assessments, driven by a team of domain experts with proven track records in their respective fields. This approach allows Selenean Capital to make informed investment decisions and provide valuable support to their portfolio companies across various sectors.

The Yield Lab was established in 2014 to address the shortage of capital and support for early-stage agriculture technology companies. Recognizing that agricultural innovation is crucial for sustainably feeding a growing global population, the firm aims to enable entrepreneurs to revolutionize agrifood systems worldwide. The Yield Lab operates through four funds across Europe, Latin America, Asia Pacific, and North America. Each regional fund invests in agrifoodtech companies ranging from seed stage to growth stage, providing not only capital but also international business connections and access to the entire Yield Lab international network. Since its founding, the firm has built a portfolio of approximately 90 companies and established a presence in four international locations. The Yield Lab continues to expand and evolve to meet the increasing demand for agricultural innovation, with the ultimate goal of sustainably feeding the world.

Feelsgood Social Impact Investment Fund is designed to invest in Croatian and Slovenian ventures that have typical private equity/venture capital for-profit-aims like commercial business models, led by strong management teams and ready to scale, but in addition can and will deliver measurable social impact. Feelsgood is spotting and supporting businesses that can find a way to address, if they already have not, one or more of the 17 Sustainable Development Goals and make measurable impact a conscious sustainable strategy of their business models.

New Vision 3 is a venture capital fund specializing in early-stage investments in tech-enabled companies driving innovation. Founded and managed by a seasoned team with a decade-long track record in startup and tech investments, the fund aims to become the preferred partner for visionary entrepreneurs contributing to the growth of the Bulgarian and regional economies. They are committed to supporting, commercializing, and globalizing the regional tech ecosystem, particularly in sectors such as FinTech, AI, Blockchain, and the Shared Economy. New Vision 3 Fund is co-financed by the European Structural and Investment Funds under the Operational Programme for Innovation and Competitiveness 2014-2020, managed by the Fund of Funds in Bulgaria, underscoring their commitment to fostering innovation and competitiveness in the region.

"Impetus Capital is an early-stage venture capital fund specializing in backing strong founding teams focused on building rapidly growing tech companies poised for global expansion. They target companies in the early stage with post-traction, typically investing initial tickets ranging from EUR 0.3m to 0.5m. Impetus Capital is committed to long-term support, particularly for companies that have demonstrated double-digit growth potential. With a strategic focus on Central and Eastern Europe (CEE), Impetus Capital prioritizes investments in CEE-based companies, with a preference for those with a Bulgarian angle. Their investment approach aims to foster growth and innovation within the region's tech ecosystem while facilitating global scalability for their portfolio companies."

TIM WCAP is the Open Innovation Program of TIM Group that promotes and facilitates the collaboration with startups, SMEs and scaleups. We promote business and collaboration opportunities between TIM Group and ready-to-market startups, SMEs and scaleups with innovative solutions in line with TIM's business needs in order to innovate the company's portfolio of products and solutions and in response to the internal demand of business units or the market demand.Areas of interest: Network IoT Cloud Cybersecurity Sustainability Continuous Scouting and Business Development to identify scaleups with innovative and sustainable solutions in response to the business needs of TIM Group. The selected companies have access to a simplified collaboration procedure.

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success.

YaraGerminate is a corporate VC-fund to support innovation in start-ups and early ventures. YaraGerminate are interested in young and innovative companies that share Yara's vision and aspirations. Most common sectors for investment is agritech, biotech and circular economy where investments are from 500 000$ to 7,5M$ pr start-up.

Leaps by Bayer invests in paradigm-shifting advances in the life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough. The firm's approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.